Ambulatory management of pulmonary embolism

被引:3
作者
Abusibah, Houssam [1 ]
Abdelaziz, Muntasir M. [2 ]
Standen, Peter [3 ]
Bhatia, Praveen [4 ]
Hamad, Mahir M. A. [3 ]
机构
[1] James Cook Univ Hosp, Dept Acute Med, Acute Med CT2, Middlesbrough, Cleveland, England
[2] Tameside Hosp, Dept Resp Med, Gen Internal Med, Ashton Under Lyne, England
[3] James Cook Univ Hosp, Dept Acute Med, Acute Med, Middlesbrough TS4 3BW, Cleveland, England
[4] Tameside Hosp, Dept Resp Med, Ashton Under Lyne, England
关键词
COMPUTED-TOMOGRAPHY; PIOPED-II; METAANALYSIS; DIAGNOSIS; RISK; RULE; THROMBOEMBOLISM; THROMBOLYSIS; FIBRINOLYSIS; CRITERIA;
D O I
10.12968/hmed.2018.79.1.18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The diagnosis of pulmonary embolism can be very difficult and elusive. It depends greatly on the use of diagnostic tests, which are in turn interpreted according to a pre-test clinical probability. These include non-specific tests such as the chest X-ray and electrocardiograph, which help exclude other conditions such as pneumonia or myocardial infarction. On the other hand, more specific tests such as computed tomography or ventilation/perfusion scanning are used to confirm or exclude the diagnosis of pulmonary embolism. The condition is potentially fatal, and in the past patients with suspected pulmonary embolism constituted a significant number of hospital admissions. Despite this, the majority were found not to have pulmonary embolism. More recently, studies have suggested that most patients with suspected pulmonary embolism who are haemodynamically stable can be safely managed on an ambulatory pathway. Therefore, there is a paradigm shift towards investigating and treating pulmonary embolism in the outpatient setting. This article discusses the ambulatory pathway of the diagnosis and treatment of pulmonary embolism.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 37 条
[1]  
Abdelaziz MM, 2012, SAUDI J INTERNAL MED, V1, P47
[2]  
Akin Muharrem, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P92, DOI 10.2174/1871529X1502151209110620
[3]   Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis [J].
Bajaj, Anurag ;
Rathor, Parul ;
Sehgal, Vishal ;
Kabak, Besher ;
Shetty, Ajay ;
Al Masalmeh, Ossama ;
Hosur, Srikanth .
LUNG, 2015, 193 (05) :639-651
[4]  
Campbell IA, 2003, THORAX, V58, P470
[5]  
Choi Won-Ho, 2009, Korean Journal of Internal Medicine, V24, P123, DOI 10.3904/kjim.2009.24.2.123
[6]  
Davies CWH, 2003, THORAX, V58, P82
[7]  
Douketis J D, 2001, Curr Opin Pulm Med, V7, P354, DOI 10.1097/00063198-200109000-00018
[8]   Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) [J].
Goldhaber, SZ ;
Visani, L ;
De Rosa, M .
LANCET, 1999, 353 (9162) :1386-1389
[9]   Perspective: Thrombolysis for pulmonary embolism [J].
Goldhaber, SZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (15) :1131-1132
[10]   Overview of prospective investigation of pulmonary embolism diagnosis II [J].
Gottschalk, A ;
Stein, PD ;
Goodman, LR ;
Sostman, HD .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (03) :173-182